BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181129
DTSTAMP:20260515T005719
CREATED:20180503T161738Z
LAST-MODIFIED:20180530T113649Z
UID:15607-1543276800-1543449599@www.pharmajournalist.com
SUMMARY:The 4BIO Summit: Europe
DESCRIPTION:4Bio Europe will feature the most cutting-edge research and technology developments in the fields of qPCR/dPCR\, NGS\, microfluidics and gene editing. Scientific advancements coupled with cost reductions in these four areas of research have contributed to the improved diagnosis\, monitoring\, and treatment of disease. \nWith similar and shared methods and applications across the four main themes of the meeting\, 4Bio Europe will provide a multi-disciplinary forum in which to discover crossover in your research\, attend the latest cutting-edge talks that appeal to you mostand network with your peers and discover solutions to the whole spectrum of your research all in one location. \nTo learn more about this event\, and to register online\, visit https://goo.gl/Vza4PY
URL:https://www.pharmajournalist.com/event/the-4bio-summit-europe/
LOCATION:Rotterdam\, Netherlands (venue TBC)
ORGANIZER;CN="Global Engage":MAILTO:anna@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181130
DTSTAMP:20260515T005719
CREATED:20181005T073033Z
LAST-MODIFIED:20181005T073033Z
UID:17885-1543276800-1543535999@www.pharmajournalist.com
SUMMARY:ICI Europe Summit 2018
DESCRIPTION:ICI Europe Summit 2018 | 27-29 November 2018 | The Sofitel Berlin Kurfuerstendamm\, Berlin \nEvidencing How Checkpoint Combinations Can Enhance Every Stage of the Cancer Immunity Cycle \nRather than covering a random selection of immuno-oncology combinations\, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle\, enhancing the long-term success of immuno-oncology drug development. \n \nCutting through the noise and hype around the immuno-oncology field\, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches. \nDon’t miss this opportunity to join Merck\, Genentech\, AstraZeneca\, Bayer\, Roche and many other leading organisations\, to empower you to make the right decisions with your IO pipeline and lay the foundations for your future success. \nAccess the complete programme to find out more about the speakers and what they will discuss: https://bit.ly/2Rr4TSI \nPharma Journalist readers are eligible for 10% discount to attend. Book online quoting VIP Code 9710PJ and you’ll automatically receive the discount. Applies to new bookings only. Cannot be used in conjunction with other offers. T&Cs apply.
URL:https://www.pharmajournalist.com/event/ici-europe-summit-2018/
LOCATION:The Sofitel Berlin Kurfuerstendamm\, Augsburger Strasse 41\, Berlin\, 10789\, Germany
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR